MENU
+Compare
KYMR
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$83.13
Change
-$0.40 (-0.48%)
Capitalization
6.65B

KYMR Kymera Therapeutics Forecast, Technical & Fundamental Analysis

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients’ lives... Show more

KYMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KYMR with price predictions
Dec 24, 2025

Momentum Indicator for KYMR turns negative, indicating new downward trend

KYMR saw its Momentum Indicator move below the 0 level on December 22, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for KYMR moved out of overbought territory on December 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where KYMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KYMR turned negative on December 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KYMR broke above its upper Bollinger Band on December 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KYMR advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 173 cases where KYMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KYMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.027) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (156.250) is also within normal values, averaging (311.015).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
KYMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KYMR is expected to report earnings to fall 15.20% to -79 cents per share on February 19

Kymera Therapeutics KYMR Stock Earnings Reports
Q4'25
Est.
$-0.80
Q3'25
Missed
by $0.18
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.11
The last earnings report on November 04 showed earnings per share of -93 cents, missing the estimate of -75 cents. With 256.54K shares outstanding, the current market capitalization sits at 6.65B.
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DUSLX43.330.18
+0.42%
DFA US Large Cap Growth Instl
RWBEX71.550.12
+0.17%
American Funds Capital World Gr&Inc R2E
TWEBX19.720.02
+0.10%
Tweedy, Browne Value
BUFMX14.720.01
+0.07%
Buffalo Mid Cap Growth
HAONX16.93N/A
N/A
Harbor International Core Investor

KYMR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.97%
NRIX - KYMR
65%
Loosely correlated
-0.26%
WVE - KYMR
54%
Loosely correlated
-2.73%
OCUL - KYMR
53%
Loosely correlated
-1.70%
VERA - KYMR
52%
Loosely correlated
+0.24%
GPCR - KYMR
51%
Loosely correlated
+12.71%
More

Groups containing KYMR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.97%
KYMR
(2 stocks)
99%
Closely correlated
-0.06%